Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Alqatab, Alaa Hashim
- Evaluation of some Coagulation Factors in Male rat with Induce Chronic Renal Failure (CRD)
Abstract Views :163 |
PDF Views:0
Authors
Affiliations
1 College of Veterinary Medicine, University of Kerbala, Karbala, IQ
1 College of Veterinary Medicine, University of Kerbala, Karbala, IQ
Source
Research Journal of Pharmacy and Technology, Vol 12, No 4 (2019), Pagination: 1871-1874Abstract
The present study conduct to investigate probable changes in coagulation factors in male rats with induced chronic renal failure (CRF). Adenine (50 mg/ kg BW) was injected intraperitoneally to 18 male rats to induce CRF and divided equally and randomly in to three groups as following: Control positive group in which CRF rats where fed with normal diet, Second group was fed with diet supplemented with Tomato powder at level 10% while animal of third group were fed with Tomato at level 20%.In addition to above mention groups sex animals introduce as control negative group and injected with DMSO only and fed with normal diet. All treatment are extended to 28 days. At the end of experiment blood was collected via heart puncture and the following (KIM-1, Creatinine, urea Fibrinogen, Factor VII, Factor VIII) was measured the result reveled present significant increase in all studied parameters in rats with induced CRF in compare with other group. In the other hand Tomato powder caused significant reduction in above mentions parameter, (in dose depended manner).Keywords
Adenine, Renal Failure, Coagulation Factor, KIM-1.
References
- Maliakel, D.M.; Kagiya, T.V. and Nair, C.K. (2008). Prevention of cisplatin induced nephrotoxicity by glucosides of ascorbic acid and alphatocopherol. ExpToxicolPathol. 60(6): 521-527.
- Kasper, D. L.; Fauci, A. S.; L-Longo, D., Braunwald, E.; Hauser, S.L. and Jameson, J.L. (2005). Harrisons' Principles of InternalMedicine.16th ed. Mc Graw-Hill, Medical Publishing Division. USA.; p 1639-1724.
- Ferguson, M. A.; Vaidya, V. S. and Bonventre, J. V.(2008). Biomarkers of nephrotoxic acute kidney injury. Toxicology; 245, 182-193.
- Finn, W. and Porter, G.(2003). Urinary biomarkers and nephrotoxicity Clinical Nephrotoxins (2nd).
- Yu, H.T. 2003. Progression of chronic renal failure. Archives. Intern. Med. 163: 1417–1429.
- Journeycake, J.M. and Buchanan, G.R.(2003).Coagulation disorders. Pediatrics in Review. 24(3):83-91.
- Lowe, G.D.; Rumley, A. and Mackie, I.J.(2004). Plasma fibrinogen. Ann Clin Biochem.41 (Pt 6):430–40.
- Liang, C.C.; Wang, S.M. and Kuo, H.L.; Chang, C.T.; Liu, J.H.; Lin, H.H.; Wang, I.K.; Yang, Y.F.; Lu, Y.J.; Chou, C.Y. and Huang, C.C.(2014). Upper gastrointestinal bleeding in patients with CKD. Clin J Am SocNephrol. 9:1354–9.
- Wattanakit, K.; Cushman, M.; Stehman-Breen, C.; Heckbert, S.R.and Folsom, A.R.(2008).Author information Chronic kidney disease increases risk for venous thromboembolism. J Am SocNephrol. 19:135–40.
- Mtiraoui, N.; Aboud, N.; Bouraoui, H.; Haizem, S.andGris, J.C. (2005). Reduction in coagulation factor VII plasma levels by R353Q but not the -323P0/10 promoter polymorphism in healthy tunisians. American Journal of Hematology; 79:11–16.
- Stoilova-McPhie, S.; Villoutreix, B.O.; Mertens, K.; Kemball-Cook, G. and Holzenburg, A.(2002). 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood; 99(4):1215-1223
- Heber, D. (2000). Colorful cancer prevention: a-carotene, lycopene and lung cancer. American Journal of Clinical Nutrition, 72, 901–902
- Rao, A. V., & Agarwal, S. (2000). Role of antioxidant lycopene in cancer and heart disease. Journal of American College of Nutrition, 19, 563–569.
- Beutner, S.; Bloedorn, B.; Frixel, S.; Blanco, I. H., Hoffmann, T.; Martin, H.; Blanco, I.H.; Hoffmann, T.; Mayer, B.; Noack, P.; Ruck, C., Marcus Schmidt, Schu¨lke, I.; Sell, S.; Ernst, H.; Haremza, S.; Seybold, G.; Sies, H.; Stahl, W.; and Walsh, R. (2001). Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: carotenoids, flavonoids, phenols and indigoids. The role of b-carotene in antioxidant functions. Journal of the Science of Food and Agriculture, 81, 559–568.
- Leonardi, C.; Ambrosino, P.; Esposito, F. and Fogliano, V. (2000). Antioxidant activity and carotenoid and tomatine contents in different typologies of fresh consumption tomatoes. Journal of Agricultural and Food Chemistry, 48, 4723–4727.
- Stewart, A. J.; Bozonnet, S.; Mullen, W.; Jenkins, G.I.; Lean, M. E. J. and Crozier, A. (2000). Occurrence of flavonols in tomatoes and tomato-based products. Journal of Agricultural and Food Chemistry.48. 2663–2669.
- Bramley, P.M.(2000). Is lycopene beneficial to human health?.Phytochemistry; 54:233–6.
- Woodall, A.A.; Lee, S.W.; Weesie, R.J.; et al.1997 Oxidation of carotenoids by free radicals: relationship between structure and reactivity. BiochemBiophysActa.1336:33–42.
- Al Za’abi1, M.; Al Busaidi, M.; Yasin, J.; Schupp, N.; Nemmar, A. and Badreldin, A.H.2015. Development of a new model for the induction of chronic kidney disease via intraperitoneal adenine administration, and the effect of treatment with gum acacia thereon. Am J Transl Res; 7(1). IP; 28-38.
- Campbell, J.K.; Engelmann, N.J.; Ann Lila, M. and Erdman, J.W.(2007). Phytoene, phytofluene, and lycopene from tomato powder differentially accumulate in tissues of male Fisher 344 rats. Nutrition Research 27.794–801
- Suganuma. H. and Inakuma. T. 1999. Protective Effect of Dietary Tomato against Endothelial Dysfunction in Hyper Cholesteremia. Biosci. Biotechnol. Biochem. 63(1). P; 78-82.
- Daniel, W.W.(1999). Biostatistic : a foundation for analysis in the health sciences.7th. John Wily. Philadelphia. p (8).
- Imarah, A.A.2017. Protective effect of Eruca Sativa leaves oil extract against induced renal failure in rats according to certain physiological and histopathological criteria. A Thesis Submitted to the Council of the Faculty of Science University of Kufa
- Sabbisetti, V.S.; Waikar, S.S.; Antoine, D.J.; Smiles. A.; Wang. C.; Ravisankar. A.; Ito, K.; Sharma, S.; Ramadesikan, S.; Lee, M.; Briskin, R.; De Jager, P.L.; Ngo, T.T.; Radlinski, M.; Dear, J.W.; Park, K.B.; Betensky, R.; Krolewski, A.S.; Bonventre, J.V. (2014). Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to esrd in type I diabetes. J. Am. Soc. Nephrol.doi: 10.1681/ASN.2013070758.
- Miao, J; Friedman, E; Wu, A. H.B; Todd, J.A; Estis, J; Xu, X; Nolan, N; Bishop, J.J and Lenihan, D.J.(2017). Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease. Clinical Biochemistry. doi: 10.1016/ j.clinbiochem.06.002
- Gowda, N.K.S. and Ledoux, D.R.( 2008). Use of antioxidants in amelioration of mycotoxin toxicity: a review. Anim. Nutr. Feed. Technol. 8, 1–11.
- Fung, F. and Clark, R.F.( 2004). Health effects of mycotoxins: a toxicological overview. J. Toxicol. Clin. Toxicol. 42, 217–234.
- Huang, M.; Wei, R.; Wang, Y.; Su, T.; Di, P.; Li, Q.; Yang, X.; Li, P.and Chen, x.(2016). Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ.7:e014294. doi:10.1136.
- Nunns, G.R.; Moore, E.E.; Chapman, M.P.; Moore, H.B.; Stettler, G.R.; Peltz, E.; Clay, C.; Burlew, b.; Christopher, C.; Silliman, d.; Banerjee, A. and Sauaia, A(.2017). The hypercoagulability paradox of chronic kidney disease:The role of fibrinogen. The American Journal of Surgery.
- Shibata, T.; Magari, Y.; Kamberi, P.; Ishii, T.; Tomo, T.; Yasumori, R. and Nasu, M.(1995). Significance of urinary fibrin/ fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases. ClinNephrol.44:91–5.
- Kario, K.; Matsuo. T.; Matsuo, M.; et al. Marked increase of activated factor VII in uremic patients. ThrombHaemost1995; 73:763–7.
- Sambola, A.; Osende, J.; Hathcock, J.; Degen, M.; Nemerson, Y.; Fuster, V.; Crandall, J. and Badimon, J.J.(2003). Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 107(7):973-977.
- Rapaport, S.I. and Rao, L.V.(1995). The tissue factor pathway: How it has become a “prima ballerina”. ThrombHaemost. 74: 7-17.
- Mackman, N.(2004). Role of tissue factor in hemostasis, thrombosis, and vascular development. ArteriosclerThrombVasc Biol. 24(6):1015-1022.
- Levi, M.; Keller, T.T.; Gorp, E. and Cate, H.(2003).Infection and inflammation and the coagulation system. Cardiovasc Res.60:26–39.
- Kaysen, G.A.(2001).The microinflammatory state in Uremia: causes and potential consequences. J Am SocNephrol; 12:1549–57.
- Yilmaza, S.; Kayaa, E.; Karacaa, A. and Karatasb, O. 2018. Aflatoxin B1 induced renal and cardiac damage in rats: Protective effect of lycopene. Research in Veterinary Science.119.P; 268–275.
- Kirstie, C.A.; Jessica, K.C.; Susan, Z.; Elizabeth, H.J. and John, W.E.(2005). The tomato as a functional food. J Nutr; 135:1226-30
- Brian, L.L.; Kirstie, C.A. and John, W.E.(2006). Lycopenoids: Are lycopene metabolites bioactive? Archives of BiochemBiophys; 458:136-40.
- Velmurugan, B.; Santhiya, S.T.andNagini, S.(2004). Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N’-nitro-N-nitrosoguanidine-induced genotoxicity. Pol J Pharmacol. 56:241-5.
- Tapiero, H.; Townsend, D.M.andTew, K.D.(2004). The role of carotenoids in the prevention of human pathologies. Biomed. Pharmacother. 58, 100–110.
- Jonker, D.; Kuper, C. and Frail, N.(2003). Ninety-day oral toxicity study of lycopene from Blakesleatrispora in rats. RegulToxico. Phamacol.37:396-406.
- Clinton, S.K.(1998). Lycopene: chemistry, biology, and implications for human health and disease. Nutr Res; 56(2):35–51.
- Bramley, P.M.(2000). Is lycopene beneficial to human health?.Phytochemistry; 54:233–6.
- John, W.; Erdman, Jr.; Ford, N.A. and Lindshield, B.R.(2009). Are the health attributes of lycopene related to its antioxidant function?. Archives of Biochemistry and Biophysics 483. P; 229–235.
- van Herpen-Broekmans, W.M.; Klopping-Ketelaars, I.A.; Bots, C.; Kluft, H.; Princen, H.F.; Hendriks, L.B.; Tijburg, G.; van Poppel, A.F. and Kardinaal, Eur. J.2004. Epidemiol. 19.915–921.sev.
- Hozawa, A.; Jacobs, J.; Steffes, M.W.; Gross, L.M.; Steffen, D.H. and Lee, Clin.(2007). Chem. 53.447–455.
- Gianetti, J.R.; Pedrinelli, R.; Petrucci, R.; Lazzerini, G.; De Caterina, M.; Bellomo, G. and Caterina, R.2002. Am. Heart J. 143. 467–474.
- Mascio, P.; Kaiser, S.andSies, H.(1989). Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys; 274, 532–538.
- Costa, J.; Pinho, O. and Monteiro, P.R. (2017). Can lycopene be considered an effective protection against cardiovascular disease?. Food Chemistry; (17)31874-5.